Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data

被引:0
|
作者
Martinelli, Francesca [1 ]
Quinten, Chantal [1 ]
Maringwa, John T. [1 ]
Coens, Corneel [1 ]
Vercauteren, Jurgen [1 ,2 ]
Cleeland, Charles S. [3 ]
Flechtner, Henning [4 ]
Gotay, Carolyn [5 ]
Greimel, Eva [6 ]
King, Madeleine [7 ]
Mendoza, Tito [3 ]
Osoba, David [8 ]
Reeve, Bryce B. [9 ]
Ringash, Jolie [10 ]
Schmucker-Von Koch, Joseph [11 ]
Shi, Qiuling [3 ]
Taphoorn, Martin J. [12 ,13 ]
Weis, Joachim [14 ]
Bottomley, Andrew [1 ]
机构
[1] European Org Res Treatment Canc, Qual Life Dept, Brussels, Belgium
[2] Katholieke Univ Leuven, Rega Inst, Louvain, Belgium
[3] Univ Texas Houston, MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA
[4] Clin Child & Adolescent Psychiat & Psychotherapy, Magdeburg, Germany
[5] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada
[6] Graz Univ, Dept Obstet & Gynecol, Graz, Austria
[7] Univ Sydney, Psychooncol Cooperat Res Grp, Sydney, NSW 2006, Australia
[8] Qual Life Consulting, W Vancouver, BC, Canada
[9] NCI, Bethesda, MD 20892 USA
[10] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[11] Univ Regensburg, Med Eth Philosoph Fac, Regensburg, Germany
[12] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[13] Med Ctr Haaglanden, The Hague, Netherlands
[14] Univ Freiburg, Dept Psychooncol, Freiburg, Germany
关键词
cancer; clinical trials; cluster analysis; patient-reported outcomes; quality of life; PHASE-III TRIAL; METASTATIC BREAST-CANCER; CELL LUNG-CANCER; EUROPEAN-ORGANIZATION; PROSTATE-CANCER; SYMPTOM CLUSTERS; COLORECTAL-CANCER; ADJUVANT THERAPY; RANDOMIZED-TRIAL; CHEMOTHERAPY;
D O I
10.1586/ERP.11.51
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Aims: Cancer patients experience multiple and concurrent health-related problems and symptoms due to their illness and therapies. The first objective of this analysis was to identify how health-related quality-of-life (HRQoL) indicators cluster among cancer patients and how possible clusters change across patients with different sociodemographic and clinical characteristics. The second objective of this study was to identify which HRQoL indicators are linked to patients' perception of overall quality of life. Methods: Retrospective pooling of 30 closed randomized European Organisation for Research and Treatment of Cancer (EORTC) clinical trials yielded baseline EORTC Quality of Life Core Questionnaire (QLQ-C30) HRQoL data for a total of 7417 patients. A cluster analysis was performed to determine how the 15 HRQoL indicators obtained with the QLQ-C30 cluster overall and by patient characteristics. Results: Three main clusters emerged from the overall dataset: a physical cluster, a psychological cluster and a gastrointestinal cluster. The same clusters were found in subgroups defined according to sociodemographic and clinical characteristics, while some differences emerged among cancer sites. The Global Health scale was found to be part of the physical cluster in the overall dataset. This result was consistent across different levels of disease severity, while divergent results were seen across some cancer sites. Conclusion: Our findings suggest that HRQoL indicators are interrelated. Understanding these relationships may aid clinicians in managing the symptom burden experienced by patients, as well as policy-makers, in defining psychosocial support plans.
引用
收藏
页码:587 / 599
页数:13
相关论文
共 50 条
  • [1] Relationships among health-related quality of life indicators in cancer patients: A pooled study of baseline EORTC QLQ-C30 data from 6,739 patients
    Martinelli, F.
    Quinten, C.
    Coens, C.
    Flechtner, H.
    Gotay, C.
    Mendoza, T.
    Osoba, D.
    Reeve, B.
    Wang, X.
    Bottomley, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Health-related quality of life indicators and overall quality of life: Results from a cluster analysis on baseline EORTC QLQ-C30 data from 6,739 cancer patients
    Coens, C.
    Martinelli, F.
    Quinten, C.
    Cleeland, C. S.
    Greimel, E.
    King, M.
    Ringash, J.
    Schmucker-Von Koch, J.
    Shi, Q.
    Bottomley, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Factor analysis of the Health-Related Quality of Life indicators of the QLQ-C30 in 6798 cancer patients
    Martinelli, F.
    Maringwa, J.
    Quinten, C.
    Coens, C.
    Cleeland, C.
    Mendoza, T.
    Reeve, B.
    Shiling, Q.
    Wang, S.
    Bottomley, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 175 - 175
  • [4] Health-related quality of life in Colombia: reference values of the EORTC QLQ-C30
    Finck, C.
    Barradas, S.
    Singer, S.
    Zenger, M.
    Hinz, A.
    EUROPEAN JOURNAL OF CANCER CARE, 2012, 21 (06) : 829 - 836
  • [5] Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials
    Maringwa, John T.
    Quinten, Chantal
    King, Madeleine
    Ringash, Jolie
    Osoba, David
    Coens, Corneel
    Martinelli, Francesca
    Vercauteren, Jurgen
    Cleeland, Charles S.
    Flechtner, Henning
    Gotay, Carolyn
    Greimel, Eva
    Taphoorn, Martin J.
    Reeve, Bryce B.
    Schmucker-Von Koch, Joseph
    Weis, Joachim
    Smit, Egbert F.
    van Meerbeeck, Jan P.
    Bottomley, Andrew
    SUPPORTIVE CARE IN CANCER, 2011, 19 (11) : 1753 - 1760
  • [6] Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials
    John T. Maringwa
    Chantal Quinten
    Madeleine King
    Jolie Ringash
    David Osoba
    Corneel Coens
    Francesca Martinelli
    Jurgen Vercauteren
    Charles S. Cleeland
    Henning Flechtner
    Carolyn Gotay
    Eva Greimel
    Martin J. Taphoorn
    Bryce B. Reeve
    Joseph Schmucker-Von Koch
    Joachim Weis
    Egbert F. Smit
    Jan P. van Meerbeeck
    Andrew Bottomley
    Supportive Care in Cancer, 2011, 19 : 1753 - 1760
  • [7] THE EORTC QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    QUALITY OF LIFE RESEARCH, 1993, 2 (01) : 51 - 52
  • [8] Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data
    Li, Leung
    Mo, Frankie K. F.
    Chan, Stephen L.
    Hui, Edwin P.
    Tang, Nelson S. L.
    Koh, Jane
    Leung, Linda K. S.
    Poon, Annette N. Y.
    Hui, Joyce
    Chu, Cheuk M.
    Lee, Kit F.
    Ma, Brigette B. Y.
    Lai, Paul B. S.
    Chan, Anthony T. C.
    Yu, Simon C. H.
    Yeo, Winnie
    BMC CANCER, 2017, 17
  • [9] Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma – clinical application of health-related quality-of-life data
    Leung Li
    Frankie KF Mo
    Stephen L Chan
    Edwin P Hui
    Nelson SL Tang
    Jane Koh
    Linda KS Leung
    Annette NY Poon
    Joyce Hui
    Cheuk M Chu
    Kit F Lee
    Brigette BY Ma
    Paul BS Lai
    Anthony TC Chan
    Simon CH Yu
    Winnie Yeo
    BMC Cancer, 17
  • [10] Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients
    Kontodimopoulos, N.
    Ntinoulis, K.
    Niakas, D.
    EUROPEAN JOURNAL OF CANCER CARE, 2011, 20 (03) : 354 - 361